UNIVERSITY OF ALABAMA AT BIRMINGHAM
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study is a funding opportunity from UNIVERSITY OF ALABAMA AT BIRMINGHAM, up to 709272, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
PROJECT SUMMARY The cardiometabolic disease burden is increasing in the United States. The atrial natriuretic peptide (ANP) hormone contributes to the regulation of glucose utilization, energy homeostasis and is a major determinant of cardiometabolic health. We have demonstrated that a common genetic variant in the…